ARWR logo

ARWR Operating Profit

Annual Operating Profit:

$98.35M+$699.43M(+116.36%)
September 30, 2025

Summary

  • As of today, ARWR annual operating income is $98.35 million, with the most recent change of +$699.43 million (+116.36%) on September 30, 2025.
  • During the last 3 years, ARWR annual operating profit has risen by +$276.85 million (+155.09%).
  • ARWR annual operating profit is now at all-time high.

Performance

ARWR Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARWRincome statement metrics

Quarterly Operating Profit:

$44.11M+$209.66M(+126.64%)
September 1, 2025

Summary

  • As of today, ARWR quarterly operating income is $44.11 million, with the most recent change of +$209.66 million (+126.64%) on September 1, 2025.
  • Over the past year, ARWR quarterly operating profit has increased by +$206.31 million (+127.19%).
  • ARWR quarterly operating profit is now -88.43% below its all-time high of $381.20 million, reached on March 31, 2025.

Performance

ARWR Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARWRincome statement metrics

TTM Operating Profit:

$98.35M+$206.31M(+191.09%)
September 1, 2025

Summary

  • As of today, ARWR TTM operating income is $98.35 million, with the most recent change of +$206.31 million (+191.09%) on September 1, 2025.
  • Over the past year, ARWR TTM operating profit has increased by +$699.43 million (+116.36%).
  • ARWR TTM operating profit is now at all-time high.

Performance

ARWR TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARWRincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

ARWR Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+116.4%+127.2%+116.4%
3Y3 Years+155.1%+152.6%+155.1%
5Y5 Years+205.6%+188.0%+205.6%

ARWR Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+116.4%-88.4%+125.0%at high+115.7%
5Y5-Yearat high+116.4%-88.4%+125.0%at high+115.7%
All-TimeAll-Timeat high+116.4%-88.4%+125.0%at high+115.7%

ARWR Operating Profit History

DateAnnualQuarterlyTTM
Sep 2025
$98.35M(+116.4%)
-
-
Sep 2025
-
$44.11M(+126.6%)
$98.35M(+191.1%)
Jun 2025
-
-$165.55M(-143.4%)
-$107.96M(+8.9%)
Mar 2025
-
$381.20M(+336.2%)
-$118.55M(+81.1%)
Dec 2024
-
-$161.41M(+0.5%)
-$625.95M(-4.1%)
Sep 2024
-$601.08M(-193.2%)
-$162.20M(+7.9%)
-$601.08M(-9.8%)
Jun 2024
-
-$176.14M(-39.6%)
-$547.21M(-15.5%)
Mar 2024
-
-$126.19M(+7.6%)
-$473.77M(-58.2%)
Dec 2023
-
-$136.54M(-26.0%)
-$299.41M(-46.1%)
Sep 2023
-$205.00M(-14.8%)
-$108.33M(-5.5%)
-$205.00M(-13.6%)
Jun 2023
-
-$102.70M(-313.2%)
-$180.50M(-19.8%)
Mar 2023
-
$48.16M(+214.3%)
-$150.71M(+4.2%)
Dec 2022
-
-$42.13M(+49.7%)
-$157.32M(+11.9%)
Sep 2022
-$178.51M(-19.8%)
-$83.83M(-15.0%)
-$178.51M(-11.9%)
Jun 2022
-
-$72.91M(-275.5%)
-$159.56M(-34.6%)
Mar 2022
-
$41.55M(+165.6%)
-$118.52M(+37.1%)
Dec 2021
-
-$63.32M(+2.4%)
-$188.30M(-26.3%)
Sep 2021
-$149.04M(-60.0%)
-$64.88M(-103.6%)
-$149.04M(-11.0%)
Jun 2021
-
-$31.87M(-12.9%)
-$134.27M(-13.5%)
Mar 2021
-
-$28.23M(-17.4%)
-$118.35M(-5.3%)
Dec 2020
-
-$24.05M(+52.0%)
-$112.36M(-20.6%)
Sep 2020
-$93.16M(-252.2%)
-$50.12M(-214.3%)
-$93.16M(-178.9%)
Jun 2020
-
-$15.95M(+28.3%)
-$33.40M(-3030.5%)
Mar 2020
-
-$22.24M(-358.2%)
$1.14M(-97.5%)
Dec 2019
-
-$4.85M(-150.4%)
$45.39M(-25.8%)
Sep 2019
$61.19M(+209.4%)
$9.64M(-48.2%)
$61.19M(+51.5%)
Jun 2019
-
$18.60M(-15.5%)
$40.38M(+588.2%)
Mar 2019
-
$22.01M(+101.1%)
$5.87M(+118.8%)
Dec 2018
-
$10.95M(+198.0%)
-$31.18M(+44.3%)
Sep 2018
-$55.94M(-51.2%)
-$11.17M(+29.8%)
-$55.94M(-1.7%)
Jun 2018
-
-$15.92M(-5.9%)
-$55.02M(-22.8%)
Mar 2018
-
-$15.03M(-8.8%)
-$44.81M(-24.8%)
Dec 2017
-
-$13.81M(-34.8%)
-$35.91M(+2.9%)
Sep 2017
-$37.00M(+56.8%)
-$10.25M(-79.4%)
-$37.00M(+29.3%)
Jun 2017
-
-$5.71M(+6.8%)
-$52.35M(+20.7%)
Mar 2017
-
-$6.13M(+58.9%)
-$65.98M(+18.7%)
Dec 2016
-
-$14.90M(+41.8%)
-$81.12M(+5.2%)
Sep 2016
-$85.55M(-1.9%)
-$25.61M(-32.4%)
-$85.55M(-2.7%)
Jun 2016
-
-$19.34M(+9.0%)
-$83.29M(-4.2%)
Mar 2016
-
-$21.26M(-9.9%)
-$79.94M(-2.3%)
Dec 2015
-
-$19.34M(+17.1%)
-$78.16M(+6.9%)
Sep 2015
-$83.94M(-72.6%)
-$23.34M(-45.9%)
-$83.94M(-7.1%)
Jun 2015
-
-$15.99M(+17.9%)
-$78.41M(-4.4%)
Mar 2015
-
-$19.49M(+22.4%)
-$75.11M(-12.4%)
Dec 2014
-
-$25.12M(-41.0%)
-$66.83M(-37.2%)
Sep 2014
-$48.64M(-122.5%)
-$17.81M(-40.2%)
-$48.73M(-29.9%)
Jun 2014
-
-$12.70M(-13.3%)
-$37.50M(-25.5%)
Mar 2014
-
-$11.21M(-60.0%)
-$29.88M(-24.2%)
Dec 2013
-
-$7.01M(-6.6%)
-$24.06M(-10.1%)
Sep 2013
-$21.86M(-3.7%)
-$6.58M(-29.4%)
-$21.86M(-5.8%)
Jun 2013
-
-$5.08M(+5.7%)
-$20.66M(+7.7%)
Mar 2013
-
-$5.39M(-12.1%)
-$22.38M(-2.4%)
Dec 2012
-
-$4.81M(+10.6%)
-$21.86M(-3.7%)
Sep 2012
-$21.09M
-$5.38M(+20.9%)
-$21.09M(-13.2%)
Jun 2012
-
-$6.80M(-39.7%)
-$18.62M(-37.0%)
DateAnnualQuarterlyTTM
Mar 2012
-
-$4.87M(-20.5%)
-$13.59M(-29.0%)
Dec 2011
-
-$4.04M(-38.7%)
-$10.53M(-40.4%)
Sep 2011
-$9.83M(-11.7%)
-$2.91M(-64.5%)
-$7.50M(-8.1%)
Jun 2011
-
-$1.77M(+2.3%)
-$6.94M(+5.4%)
Mar 2011
-
-$1.81M(-79.5%)
-$7.33M(+4.2%)
Dec 2010
-
-$1.01M(+57.0%)
-$7.65M(+13.1%)
Sep 2010
-$8.80M(+49.5%)
-$2.35M(-8.5%)
-$8.80M(+9.8%)
Jun 2010
-
-$2.16M(-1.6%)
-$9.76M(+1.6%)
Mar 2010
-
-$2.13M(+1.4%)
-$9.92M(+11.5%)
Dec 2009
-
-$2.16M(+34.7%)
-$11.21M(+21.7%)
Sep 2009
-$17.44M(+45.0%)
-$3.31M(-42.3%)
-$14.32M(+36.6%)
Jun 2009
-
-$2.32M(+32.0%)
-$22.57M(+25.1%)
Mar 2009
-
-$3.42M(+35.2%)
-$30.15M(+10.8%)
Dec 2008
-
-$5.27M(+54.4%)
-$33.80M(+4.5%)
Sep 2008
-$31.73M(-11.9%)
-$11.56M(-16.8%)
-$35.41M(+0.2%)
Jun 2008
-
-$9.90M(-39.9%)
-$35.50M(+9.0%)
Mar 2008
-
-$7.07M(-2.7%)
-$39.00M(+3.4%)
Dec 2007
-
-$6.89M(+40.9%)
-$40.36M(-6.4%)
Sep 2007
-$28.35M(-38.4%)
-$11.64M(+13.1%)
-$37.95M(-11.4%)
Jun 2007
-
-$13.40M(-58.9%)
-$34.06M(-35.4%)
Mar 2007
-
-$8.43M(-88.5%)
-$25.15M(-21.7%)
Dec 2006
-
-$4.47M(+42.4%)
-$20.66M(-2.1%)
Sep 2006
-$20.48M(-118.8%)
-$7.76M(-73.1%)
-$20.24M(-40.8%)
Jun 2006
-
-$4.48M(-13.6%)
-$14.37M(-8.5%)
Mar 2006
-
-$3.95M(+2.7%)
-$13.25M(-17.2%)
Dec 2005
-
-$4.05M(-114.0%)
-$11.30M(-22.9%)
Sep 2005
-$9.36M(-238.1%)
-$1.89M(+43.6%)
-$9.20M(-4.5%)
Jun 2005
-
-$3.36M(-67.7%)
-$8.80M(-45.7%)
Mar 2005
-
-$2.00M(-2.9%)
-$6.04M(-32.2%)
Dec 2004
-
-$1.94M(-29.8%)
-$4.57M(-65.1%)
Sep 2004
-$2.77M(-2833.2%)
-$1.50M(-151.4%)
-$2.77M(-115.0%)
Jun 2004
-
-$596.00K(-12.1%)
-$1.29M(-82.2%)
Mar 2004
-
-$531.50K(-273.0%)
-$706.70K(-245.2%)
Dec 2003
-
-$142.50K(-709.7%)
-$204.70K(-116.6%)
Sep 2003
-$94.40K(+33.3%)
-$17.60K(-16.6%)
-$94.50K(-22.9%)
Jun 2003
-
-$15.10K(+48.8%)
-$76.90K(+30.5%)
Mar 2003
-
-$29.50K(+8.7%)
-$110.70K(-6.9%)
Dec 2002
-
-$32.30K(+33.9%)
-$103.60K(-6.8%)
Sep 2002
-$141.60K(-33.2%)
-
-
Jun 2002
-
-$48.90K(-118.3%)
-$97.00K(-52.5%)
Mar 2002
-
-$22.40K(+12.8%)
-$63.60K(+4.6%)
Dec 2001
-
-$25.70K(-65.8%)
-$66.70K(+35.9%)
Sep 2001
-$106.30K(+2.7%)
-
-
Jun 2001
-
-$15.50K(+39.2%)
-$104.10K(+6.9%)
Mar 2001
-
-$25.50K(+28.0%)
-$111.80K(0.0%)
Dec 2000
-
-$35.40K(-27.8%)
-$111.80K(-2.3%)
Sep 2000
-$109.20K(-94.3%)
-$27.70K(-19.4%)
-$109.30K(-30.7%)
Jun 2000
-
-$23.20K(+9.0%)
-$83.60K(-6.4%)
Mar 2000
-
-$25.50K(+22.5%)
-$78.60K(-14.1%)
Dec 1999
-
-$32.90K(-1545.0%)
-$68.90K(-91.4%)
Sep 1999
-$56.20K(-32.9%)
-$2000.00(+89.0%)
-$36.00K(-5.9%)
Jun 1999
-
-$18.20K(-15.2%)
-$34.00K(-115.2%)
Mar 1999
-
-$15.80K
-$15.80K
Sep 1998
-$42.30K(+73.3%)
-
-
Sep 1997
-$158.60K
-
-

FAQ

  • What is Arrowhead Pharmaceuticals, Inc. annual operating income?
  • What is the all-time high annual operating profit for Arrowhead Pharmaceuticals, Inc.?
  • What is Arrowhead Pharmaceuticals, Inc. annual operating profit year-on-year change?
  • What is Arrowhead Pharmaceuticals, Inc. quarterly operating income?
  • What is the all-time high quarterly operating profit for Arrowhead Pharmaceuticals, Inc.?
  • What is Arrowhead Pharmaceuticals, Inc. quarterly operating profit year-on-year change?
  • What is Arrowhead Pharmaceuticals, Inc. TTM operating income?
  • What is the all-time high TTM operating profit for Arrowhead Pharmaceuticals, Inc.?
  • What is Arrowhead Pharmaceuticals, Inc. TTM operating profit year-on-year change?

What is Arrowhead Pharmaceuticals, Inc. annual operating income?

The current annual operating profit of ARWR is $98.35M

What is the all-time high annual operating profit for Arrowhead Pharmaceuticals, Inc.?

Arrowhead Pharmaceuticals, Inc. all-time high annual operating income is $98.35M

What is Arrowhead Pharmaceuticals, Inc. annual operating profit year-on-year change?

Over the past year, ARWR annual operating income has changed by +$699.43M (+116.36%)

What is Arrowhead Pharmaceuticals, Inc. quarterly operating income?

The current quarterly operating profit of ARWR is $44.11M

What is the all-time high quarterly operating profit for Arrowhead Pharmaceuticals, Inc.?

Arrowhead Pharmaceuticals, Inc. all-time high quarterly operating income is $381.20M

What is Arrowhead Pharmaceuticals, Inc. quarterly operating profit year-on-year change?

Over the past year, ARWR quarterly operating income has changed by +$206.31M (+127.19%)

What is Arrowhead Pharmaceuticals, Inc. TTM operating income?

The current TTM operating profit of ARWR is $98.35M

What is the all-time high TTM operating profit for Arrowhead Pharmaceuticals, Inc.?

Arrowhead Pharmaceuticals, Inc. all-time high TTM operating income is $98.35M

What is Arrowhead Pharmaceuticals, Inc. TTM operating profit year-on-year change?

Over the past year, ARWR TTM operating income has changed by +$699.43M (+116.36%)
On this page